RECRUITING

Bridging the Evidence-to-practice Gap

Description

The proposed project will address this evidence-to-practice gap by evaluating the effect of practice facilitation (PF) of the intervention implementation fidelity (primary outcome) and clinical measures at 12 months (secondary outcomes).

Conditions

Hypertension
Talk to us

Related Conditions:

Hypertension

Study Overview

On this page

Study Details

Study overview

The proposed project will address this evidence-to-practice gap by evaluating the effect of practice facilitation (PF) of the intervention implementation fidelity (primary outcome) and clinical measures at 12 months (secondary outcomes).

Bridging the Evidence-to-practice Gap: Evaluating Practice Facilitation as a Strategy to Accelerate Translation of a Systems-level Adherence Intervention Into Safety Net Practices

Bridging the Evidence-to-practice Gap

Condition
Hypertension
Intervention / Treatment

-

Contacts and Locations

New York

NYUMC Langone, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Self-identify as Latino
  • * Be fluent in English or Spanish
  • * Be age 18 years or older
  • * Receiving care in a safety-net primary care practice
  • * Have uncontrolled HTN documented in the electronic health record (EHR) on at least two visits in the past year (defined as an average BP ≥ 140/90 mmHg)
  • * Have been prescribed at least one anti-hypertensive medication and be non- adherent to their medications, defined as adherence \<80% in the preceding 12 months, as determined by prescription orders obtained from the clinic EHR.
  • * Being deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks)
  • * Participation in other hypertension-related clinical trials
  • * Have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR)
  • * Plan to discontinue care at their practice within the next 12 months

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Antoinette Schoenthaler, EdD, PRINCIPAL_INVESTIGATOR, NYUMC Langone

Study Record Dates

2027-11-30